This article was written by Follow Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment […]
Prothena Stock Surges After Parkinson’s Drug Misses Primary Endpoint (NASDAQ:PRTA) Read More »
This article was written by Follow Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment
Sell Dollar Tree Heading Into Q3 Earnings (NASDAQ:DLTR) Read More »
Novo Nordisk: A GLP-1 Leader Faces Increasing Competition Source link Brendan O'Boyle
Novo Nordisk: A GLP-1 Leader Faces Increasing Competition Read More »
Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial Source link Brendan O'Boyle
Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial Read More »
